Drug Trial Radar · NCT01552902
Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
Last checked: Nov 19, 2026Latest source record: Jun 10, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
549
Actual
Start
Apr 3, 2012
Primary completion
May 22, 2014
Study completion May 22, 2014
Sponsor
- Lead sponsor
- ShireTakeda (TAK)
- Sponsor type
- Industry
- First posted
- Mar 13, 2012
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 13 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine effectiveness of Vyvanse compared to Concerta in adolescents with Attention-deficit/Hyperactivity Disorder (ADHD).
Conditions
- Attention-deficit/Hyperactivity Disorder
Interventions
Lisdexamfetamine dimesylateDrug
Daily oral dosing in the AM ranging from 30- 70 mg. 4 week forced dose titration, 2 week dose maintenance
Methylphenidate HydrochlorideDrug
Daily oral dosing in the AM ranging from 18-72 mg. 4 week force dose titration, 2 week dose maintenance
PlaceboDrug
Daily oral dosing in the AM for 6 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Attention-Deficit/Hyperactivity Disorder Rating Scale, Fourth Edition (ADHD-RS-IV) Total Score at Week 6Time frame: Baseline, Week 6
Locations
95 sites in 5 countries. Site status is shown where the registry gives one.
Harmonex Neuroscience Research, Inc.
Dothan, Alabama
Center for Advanced Improvement
Tucson, Arizona
Clinical Study Centers, LLC
Little Rock, Arkansas
Shanti Clinical Trials
Colton, California
Sun Valley Research Center
Imperial, California
Synergy Clinical Research Center
National City, California
Pacific Sleep Medicine, A Medical Corporation
Oceanside, California
Neuropsychiatric Research Center for Orange County
Orange, California
Peninsula Research Associates
Rolling Hills Estates, California
PCSD - Feighner Research
San Diego, California
University of California, San Francisco
San Francisco, California
Encompass Clinical Research
Spring Valley, California
Elite Clinical Trials
Wildomar, California
IMMUNOe International Research Center
Centennial, Colorado
MCB Clinical Research Centers, LLC
Colorado Springs, Colorado
Coastal Connecticut Research, LLC
New London, Connecticut
Florida Clinical Research Center, LLC
Bradenton, Florida
Amedica Research Institute, Inc
Hialeah, Florida
Clinical Neuroscience Solutions, Inc
Jacksonville, Florida
Sarkis Clinical Trials
Lake City, Florida
Florida Clinical Research Center, LLC
Maitland, Florida
Prevention & Strengthening Solutions, Inc.
Miami, Florida
Scientific Clinical Research, Inc.
North Miami, Florida
Medical Research Group of Central Florida
Orange City, Florida
Clinical Neuroscience Solutions, Inc.
Orlando, Florida
Compass Research, LLC
Orlando, Florida
Miami Research Associates
South Miami, Florida
Stedman Clinical Trials
Tampa, Florida
Atlanta Institute of Medicine & Research, Inc
Atlanta, Georgia
Clinical Research Center, University of Illinois at Chicago
Chicago, Illinois
Capstone Clinical Research
Libertyville, Illinois
Baber Research Group
Naperville, Illinois
Pedia Research, LLC
Newburgh, Indiana
Psychiatric Associates
Overland Park, Kansas
Pedia Research, LLC
Owensboro, Kentucky
Louisiana Resarch Associates, Inc.
New Orleans, Louisiana
Marc Hertzman, MD, PC
Rockville, Maryland
Rochester Center for Behavioral Medicine
Rochester Hills, Michigan
Clinical Neurophysiology Services, PC
Sterling Heights, Michigan
Behavioral Medical Center - Troy
Troy, Michigan
Showing 40 of 95 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.